Dose-finding Study of MCI-196

Summary

The Primary Objective of this study is to determine the initial starting doses of colestilan (MCI-196) in paediatric subjects with Chronic Kidney Disease Stage 5 on Dialysis and with Hyperphosphataemia.

Timeline

Start

2014-04

Primary completion

2015-01

Completion

2015-01

Outcome

Outcome not reported

Stopped (Enrollment): “This study has been terminated because of insufficient patient recruitment.”

Drugs

Indications